{
    "2021-12-08": [
        [
            {
                "time": "2023-10-05",
                "original_text": "New KisqaliÂ® data shows consistent overall survival benefit across genomic and clinical subtypes of interest in HR+/HER2- metastatic breast cancer",
                "features": {
                    "keywords": [
                        "Kisqali",
                        "consistent survival benefit",
                        "HR+/HER2-",
                        "metastatic breast cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Alcon Finance Corporation -- Moody's announces completion of a periodic review of ratings of Alcon Inc.",
                "features": {
                    "keywords": [
                        "Moody's",
                        "rating review",
                        "Alcon Inc."
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Ionis (IONS) Collaborates With AstraZeneca for Eplontersen",
                "features": {
                    "keywords": [
                        "Ionis",
                        "AstraZeneca",
                        "Eplontersen",
                        "collaboration"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}